AUD272.31
0.68% today
Australia, Jun 12, 08:10 am CET
ISIN
AU000000COH5
Symbol
COH
Sector

Cochlear Stock price

AUD272.31
+6.51 2.45% 1M
-15.88 5.51% 6M
-15.26 5.31% YTD
-47.36 14.82% 1Y
+92.08 51.09% 5Y
+202.15 288.14% 10Y
+249.64 1,101.02% 20Y
Australia, Closing price Thu, Jun 12 2025
+1.85 0.68%
ISIN
AU000000COH5
Symbol
COH
Sector

Key metrics

Market capitalization AUD17.63b
Enterprise Value AUD17.49b
P/E (TTM) P/E ratio 47.95
EV/FCF (TTM) EV/FCF 69.80
EV/Sales (TTM) EV/Sales 7.58
P/S ratio (TTM) P/S ratio 7.63
P/B ratio (TTM) P/B ratio 9.48
Dividend yield 1.52%
Last dividend (FY24) AUD4.10
Revenue growth (TTM) Revenue growth 7.42%
Revenue (TTM) Revenue AUD2.31b
EBIT (operating result TTM) EBIT AUD536.30m
Free Cash Flow (TTM) Free Cash Flow AUD250.60m
Cash position AUD383.10m
EPS (TTM) EPS AUD5.64
P/E forward 43.27
P/S forward 7.31
EV/Sales forward 7.25
Show more

Is Cochlear a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,840 stocks worldwide.

Cochlear Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Cochlear forecast:

5x Buy
38%
7x Hold
54%
1x Sell
8%

Analyst Opinions

13 Analysts have issued a Cochlear forecast:

Buy
38%
Hold
54%
Sell
8%

Financial data from Cochlear

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
2,309 2,309
7% 7%
100%
- Direct Costs 560 560
6% 6%
24%
1,749 1,749
8% 8%
76%
- Selling and Administrative Expenses 936 936
7% 7%
41%
- Research and Development Expense 294 294
9% 9%
13%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 536 536
9% 9%
23%
Net Profit 371 371
6% 6%
16%

In millions AUD.

Don't miss a Thing! We will send you all news about Cochlear directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Cochlear Ltd. engages in the provision of implantable hearing solutions. The firm operates through the following segments: Americas, Europe and Asia Pacific. Its products include cochlear, bone conduction and acoustic implants. The company was founded by Michael S. Hirshorn in 1981 and is headquartered in Sydney, Australia.

Head office Australia
CEO Diggory Howitt
Employees 5,047
Founded 1983
Website www.cochlear.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today